Lido Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Lido Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$501K	Buy	1,000 +400	+67%	+$192K	﹤0.01%	1474
2026 Q1	$295K	Sell	600 -1,100	-65%	-$597K	﹤0.01%	1575
2025 Q4	$985K	Hold	1,700	–	–	﹤0.01%	1011
2025 Q3	$825K	Hold	1,700	–	–	﹤0.01%	1036
2025 Q2	$689K	Buy	1,700 +1,300	+325%	+$544K	﹤0.01%	989
2025 Q1	$199K	Sell	400 -400	-50%	-$217K	﹤0.01%	1393
2024 Q4	$416K	Sell	800 -200	-20%	-$110K	﹤0.01%	1073
2024 Q3	$619K	Buy	1,000 +400	+67%	+$237K	﹤0.01%	879
2024 Q2	$332K	Buy	600 +400	+200%	+$229K	﹤0.01%	1070
2024 Q1	$116K	Sell	200 -400	-67%	-$224K	﹤0.01%	1313
2023 Q4	$318K	Sell	600 -200	-25%	-$96.8K	﹤0.01%	1010
2023 Q3	$405K	Buy	800 +200	+33%	+$107K	﹤0.01%	805
2023 Q2	$313K	Hold	600	–	–	﹤0.01%	910
2023 Q1	$346K	Hold	600	–	–	﹤0.01%	829
2022 Q4	$330K	Buy	+600	New	+$318K	﹤0.01%	763
2019 Q4	–	Sell	-1,300	Closed	-$378K	–	684
2019 Q3	$378K	Hold	1,300	–	–	0.02%	401
2019 Q2	$381K	Hold	1,300	–	–	0.02%	366
2019 Q1	$355K	Buy	+1,300	New	+$324K	0.02%	354

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Lido Advisors's TMO Position: Q2 2026 in Review

Lido Advisors increased its Thermo Fisher Scientific (TMO) stake by 7.8% in Q2 2026, buying an estimated $1.5M and bringing the position to 43,094 shares worth $21.6M. The position accounts for 0.06% of the portfolio, ranked #215.

Lido Advisors first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $22.9M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Lido Advisors held 43,094 shares of Thermo Fisher Scientific worth $21.6M as of Q2 2026.
Lido Advisors bought 3,116 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.5M.
Thermo Fisher Scientific made up 0.06% of Lido Advisors's portfolio in Q2 2026, its #215 holding.
Lido Advisors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
Lido Advisors's Thermo Fisher Scientific position peaked at $22.9M in Q4 2025.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.